EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Penggunaan Bioteknologi Dalam Meningkatkan Efektivitas dan Keamanan Obat Biologis: Tinjauan Literatur Sistematis

Adelia Puspita, Febronia Ammuni, Yemima Honin, Anna Yuliana

Media Farmasi · 31.10.2026 · 22 (2) · 126-138

DOI: 10.32382/mf.v22i2.2367 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Media Farmasi, online erschienen am 31.10.2026. Verfasst von Adelia Puspita und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of biotechnology in improving the efficacy and safety of biological drugs: A systematic literature review Biotechnology is an important approach in the development of biological drugs through the application of cell culture technology, genetic engineering, cell-based therapy, and therapeutic protein development. This study aims to analyze the contribution of biotechnology approaches in the development of biological drugs, particularly regarding production, product quality, safety aspects, and challenges in clinical implementation. A Systematic Literature Review (SLR) method was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Literature identification and selection were performed using Google Scholar and Scopus databases for publications from 2017 to 2025. Among 50 identified articles, 8 articles met the inclusion criteria and were included in the final synthesis. The results indicate that cell culture technology, particularly the Chinese hamster ovary (CHO) cell expression system, plays an important role in producing therapeutic proteins such as monoclonal antibodies. Furthermore, gene therapy, cell-based therapy, and biologically derived enzyme products demonstrate potential in developing more specific therapeutic approaches. Safety evaluation through pharmacovigilance and strengthening regulatory systems are also essential aspects in biological drug development. However, biotechnology implementation still faces challenges, including complex manufacturing processes, the need for long-term clinical validation, and differences in regulatory standards. In conclusion, biotechnology plays a strategic role in supporting biological drug development by improving production quality, strengthening safety evaluation, and promoting innovative therapeutic approaches that require further research for optimal clinical application. Bioteknologi merupakan salah satu pendekatan penting dalam pengembangan obat biologis melalui penerapan teknologi kultur sel, rekayasa genetik, terapi berbasis sel, serta pengembangan protein terapeutik. Penelitian ini bertujuan untuk menganalisis kontribusi pendekatan bioteknologi dalam pengembangan obat biologis, khususnya terkait aspek produksi, kualitas produk, keamanan, dan tantangan penerapan klinis. Metode yang digunakan adalah Systematic Literature Review (SLR) dengan pedoman Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Proses identifikasi dan seleksi artikel dilakukan menggunakan basis data Google Scholar dan Scopus terhadap publikasi periode 2017–2025. Dari 50 artikel yang teridentifikasi, sebanyak 8 artikel memenuhi kriteria inklusi dan dianalisis dalam sintesis akhir. Hasil kajian menunjukkan bahwa teknologi kultur sel, khususnya sistem ekspresi Chinese hamster ovary (CHO) cells, berperan penting dalam produksi protein terapeutik seperti antibodi monoklonal. Selain itu, teknologi terapi gen, terapi sel, serta pengembangan produk biologis berbasis enzim menunjukkan potensi dalam menghasilkan terapi yang lebih spesifik. Aspek keamanan juga menjadi perhatian utama melalui penerapan farmakovigilans dan penguatan regulasi produk biologis. Namun, penerapan bioteknologi masih menghadapi tantangan berupa kompleksitas proses produksi, kebutuhan validasi klinis jangka panjang, serta perbedaan standar regulasi. Berdasarkan hasil kajian, bioteknologi memiliki peran strategis dalam mendukung pengembangan obat biologis melalui peningkatan kualitas produksi, pengendalian keamanan, dan pengembangan terapi inovatif yang memerlukan penelitian lanjutan untuk optimalisasi penerapan klinis.

Zitieren

APA

Puspita, A., Ammuni, F., Honin, Y., & Yuliana, A. (2026). Penggunaan Bioteknologi Dalam Meningkatkan Efektivitas dan Keamanan Obat Biologis: Tinjauan Literatur Sistematis. Media Farmasi, 22(2), 126-138. https://doi.org/10.32382/mf.v22i2.2367

Vancouver

Puspita A, Ammuni F, Honin Y, Yuliana A. Penggunaan Bioteknologi Dalam Meningkatkan Efektivitas dan Keamanan Obat Biologis: Tinjauan Literatur Sistematis. Media Farmasi. 2026;22(2):126-138. doi:10.32382/mf.v22i2.2367

BibTeX
@article{Puspita2026,
  author = {Puspita, Adelia and Ammuni, Febronia and Honin, Yemima and Yuliana, Anna},
  title = {Penggunaan Bioteknologi Dalam Meningkatkan Efektivitas dan Keamanan Obat Biologis: Tinjauan Literatur Sistematis},
  journal = {Media Farmasi},
  year = {2026},
  volume = {22},
  number = {2},
  pages = {126--138},
  doi = {10.32382/mf.v22i2.2367}
}
Kostenlos starten →